Amryt Pharma

Signs distribution agreement

  • Sectors : Pharma and healthcare
  • Companies : Amryt Pharma

Ratings and price correct at time of issue.

  • Amryt Pharma

    Closing Price: 1913p

  • RATING 14/09/17

  • PREVIOUS RATING N/A

DAVY VIEW

Amryt has signed an exclusive distribution agreement with El Seif, a Saudi Arabian distributor of medical devices and pharmaceuticals. The agreement covers its commercial product Lojuxta and its late stage clinical drug AP101. This is an important milestone for Amryt as it establishes a presence in the key commercial territory of Saudi Arabia and is indicative of the company’s broader strategy to extend its footprint across key territories.

Download full report with analyst certification and important disclosures

Nov 13 2017, 08:40 GMT

Download